5-hydroxy omeprazole,
5-hydroxymethylomeprazole,
5-methoxy-2-(((4-methoxy-3-methyl-5-hydroxymethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole,
hydroxyomeprazole,
5-HYDROXY OMEPRAZOLE,
Hydroxyomeprazole,
92340-57-3,
5-HYDROXYOMEPRAZOLE,
5'-Hydroxyomeprazole,
CHEBI:63840,
5-Methoxy-2-(((4-methoxy-3-methyl-5-hydroxymethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole,
5'-Hydroxyomeprazole, R-,
UNII-JOT1NT1B70,
5-Hydroxymethylomeprazole,
JOT1NT1B70,
196489-26-6,
P450 (CYP) metabolite|||Phase I metabolite of omeprazole|||CYP2C19 reference metabolite,
AC1Q6YJT,
(4-methoxy-6-{[(6-methoxy-1h-benzimidazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol,
AC1L3P18,
SCHEMBL3058978,
CHEMBL3527071,
AKOS005146284,
4-Methoxy-6-(((5-methoxy-1H-benzimidazol-2-yl)sulfinyl)methyl)-5-methyl-3-pyridinemethanol,
5-Hydroxyomeprazole, analytical standard,
FT-0081176,
FT-0651053,
340H573,
(4-methoxy-6-((5-methoxy-1H-benzo[d]imidazol-2-ylsulfinyl)methyl)-5-methylpyridin-3-yl)methanol,
(4-methoxy-6-{[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol,
[4-methoxy-6-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methylpyridin-3-yl]methanol,
{4-methoxy-6-[(6-methoxy-1H-1,3-benzodiazole-2-sulfinyl)methyl]-5-methylpyridin-3-yl}methanol,
3-Pyridinemethanol, 4-methoxy-6-(((5-methoxy-1H-benzimidazol-2-yl)sulfinyl)methyl)-5-methyl-,
5-Hydroxyesomeprazole,
5/'-Hydroxyomeprazole, R-,
KST-1A9218,
AR-1A5882,
C17-H19-N3-O4-S,
CID119560,
C049963,
981-24-8,